• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HA-透明质酸酶尿液检测。一种用于检测膀胱癌并评估其分级的灵敏且特异的方法。

HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.

作者信息

Lokeshwar V B, Block N L

机构信息

Department of Urology, University of Miami School of Medicine, Florida, USA.

出版信息

Urol Clin North Am. 2000 Feb;27(1):53-61. doi: 10.1016/s0094-0143(05)70234-2.

DOI:10.1016/s0094-0143(05)70234-2
PMID:10696245
Abstract

Hyaluronic acid and HAase are intricately associated with the biology of bladder tumor angiogenesis and metastasis. Tumor-associated HA and HAase are secreted in urine. In G2 and G3 bladder tumors, HA is degraded by HAase, resulting in the generation of angiogenic HA fragments, which, in turn, are secreted in urine. An elevated urinary HA level (> or = 500 ng/mg), indicating a positive HA test, suggests the presence of bladder cancer regardless of tumor grade. The urinary HAase levels correlate with the malignant potential of bladder cancer and are elevated (> or = 10 mU/mg) in the urine of patients with G2 and G3 bladder cancer. Combining the results from the HA and the HAase tests (the HA-HAase test) yields inferences, including the detection of bladder cancer and the evaluation of its grade. The overall 92% sensitivity of the HA-HAase test to detect bladder cancer is higher than the sensitivity of individual tests with little compromise in specificity. The HA-HAase test is equally sensitive for monitoring tumor recurrence. When compared with existing noninvasive tests, the HA-HAase test may be significantly less expensive and more accurate.

摘要

透明质酸(HA)和透明质酸酶(HAase)与膀胱肿瘤血管生成及转移的生物学过程密切相关。肿瘤相关的HA和HAase会分泌到尿液中。在G2和G3级膀胱肿瘤中,HA会被HAase降解,从而产生促血管生成的HA片段,这些片段继而分泌到尿液中。尿HA水平升高(≥500 ng/mg),即HA检测呈阳性,提示存在膀胱癌,而与肿瘤分级无关。尿HAase水平与膀胱癌的恶性潜能相关,在G2和G3级膀胱癌患者的尿液中升高(≥10 mU/mg)。结合HA和HAase检测结果(HA-HAase检测)可得出推论,包括膀胱癌的检测及其分级评估。HA-HAase检测对膀胱癌检测的总体敏感性为92%,高于单项检测的敏感性,且特异性几乎没有损失。HA-HAase检测对监测肿瘤复发同样敏感。与现有的非侵入性检测相比,HA-HAase检测可能成本显著更低且更准确。

相似文献

1
HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.HA-透明质酸酶尿液检测。一种用于检测膀胱癌并评估其分级的灵敏且特异的方法。
Urol Clin North Am. 2000 Feb;27(1):53-61. doi: 10.1016/s0094-0143(05)70234-2.
2
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.尿透明质酸和透明质酸酶:膀胱癌检测及分级评估的标志物。
J Urol. 2000 Jan;163(1):348-56. doi: 10.1016/s0022-5347(05)68050-0.
3
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].[透明质酸与透明质酸酶。两种新型膀胱癌标志物]
Urologe A. 2001 Mar;40(2):121-6. doi: 10.1007/s001200050449.
4
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.用于监测复发的膀胱肿瘤标志物以及透明质酸-透明质酸酶与BTA-Stat检测的筛查比较
Cancer. 2002 Jul 1;95(1):61-72. doi: 10.1002/cncr.10652.
5
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.免疫细胞检测和HA-HAase尿液检测用于膀胱癌检测:并列比较
Eur Urol. 2004 Oct;46(4):466-71. doi: 10.1016/j.eururo.2004.06.006.
6
Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.尿透明质酸和透明质酸酶检测膀胱移行细胞癌的敏感性和特异性
Urol J. 2014 Mar 3;11(1):1232-7.
7
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.透明质酸和透明质酸酶的组织表达升高验证了用于膀胱癌的HA-HAase尿液检测。
J Urol. 2001 Jun;165(6 Pt 1):2068-74. doi: 10.1097/00005392-200106000-00072.
8
Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer.透明质酸和透明质酸酶作为前列腺癌诊断的潜在新型尿液生物标志物。
Med Oncol. 2018 May 25;35(7):97. doi: 10.1007/s12032-018-1157-9.
9
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.肿瘤相关透明质酸:一种用于膀胱癌的新型灵敏且特异的尿液标志物。
Cancer Res. 1997 Feb 15;57(4):773-7.
10
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.肿瘤标志物透明质酸和透明质酸酶(HYAL1)在头颈部肿瘤中的表达。
Int J Cancer. 2003 Sep 1;106(3):438-45. doi: 10.1002/ijc.11252.

引用本文的文献

1
Inverted Pyramid Nanostructures Coupled with a Sandwich Immunoassay for SERS Biomarker Detection.用于表面增强拉曼散射生物标志物检测的倒置金字塔纳米结构与夹心免疫分析联用
Nanomaterials (Basel). 2025 Jan 2;15(1):64. doi: 10.3390/nano15010064.
2
Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer.用于诊断或检测膀胱癌复发的非侵入性尿液检测
Cancers (Basel). 2021 Apr 1;13(7):1650. doi: 10.3390/cancers13071650.
3
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer.
一种新型 HYAL-4 剪接变体驱动膀胱癌恶性转化并预测患者预后。
Clin Cancer Res. 2020 Jul 1;26(13):3455-3467. doi: 10.1158/1078-0432.CCR-19-2912. Epub 2020 Feb 24.
4
Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.膀胱癌的诊断和随访:细胞外囊泡的现状和可能作用。
Int J Mol Sci. 2019 Feb 14;20(4):821. doi: 10.3390/ijms20040821.
5
FRET based ratio-metric sensing of hyaluronidase in synthetic urine as a biomarker for bladder and prostate cancer.基于荧光共振能量转移的合成尿液中透明质酸酶比率测量传感作为膀胱癌和前列腺癌的生物标志物
Curr Pharm Biotechnol. 2013;14(4):470-4. doi: 10.2174/13892010113149990222.
6
Urine cytology and adjunct markers for detection and surveillance of bladder cancer.用于膀胱癌检测和监测的尿液细胞学及辅助标志物。
Am J Transl Res. 2010 Jul 25;2(4):412-40.
7
Urinary hyaluronidase activity in rats infected with Blastocystis hominis--evidence for invasion?大鼠感染人芽囊原虫后尿液透明质酸酶活性的变化——是否存在入侵的证据?
Parasitol Res. 2010 May;106(6):1459-63. doi: 10.1007/s00436-010-1825-y. Epub 2010 Apr 1.
8
Urine-based assays for the detection of bladder cancer.用于检测膀胱癌的尿液检测方法。
Biomark Med. 2009 Jun 1;3(3):265. doi: 10.2217/bmm.09.23.
9
Critical evaluation of urinary markers for bladder cancer detection and monitoring.用于膀胱癌检测和监测的尿液标志物的批判性评估。
Rev Urol. 2008 Spring;10(2):120-35.
10
Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?膀胱肿瘤标志物:从血尿到分子诊断——我们目前的状况如何?
Expert Rev Anticancer Ther. 2008 Jul;8(7):1111-23. doi: 10.1586/14737140.8.7.1111.